Loading organizations...
Loading organizations...
Developer of cell-based immunotherapies for cancer treatment.
JW Therapeutics has raised $90.0M across 1 funding round.
JW Therapeutics has raised $90.0M in total across 1 funding round.
JW Therapeutics has raised $90.0M in total across 1 funding round.
JW Therapeutics's investors include Hongshan Capital Group (Sequoia Capital China), Temasek, YuanMing Capital, AVICT Global, Juno Therapeutics, WuXi AppTec, Yipu Capital.
JW Therapeutics has raised $90.0M across 1 funding round. Most recently, it raised $90.0M Series A in March 2018.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 8, 2018 | $90.0M Series A | Hongshan Capital Group (Sequoia Capital China), Temasek, YuanMing Capital | AVICT Global, Juno Therapeutics, WuXi AppTec, Yipu Capital |